<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34354243</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1935-3456</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>6</Issue><PubDate><Year>2021</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Mucosal immunology</Title><ISOAbbreviation>Mucosal Immunol</ISOAbbreviation></Journal><ArticleTitle>Deficient inflammasome activation permits an exaggerated asthma phenotype in rhinovirus C-infected immature mice.</ArticleTitle><Pagination><StartPage>1369</StartPage><EndPage>1380</EndPage><MedlinePgn>1369-1380</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41385-021-00436-0</ELocationID><Abstract><AbstractText>Compared to other RV species, RV-C has been associated with more severe respiratory illness and is more likely to occur in children with a history of asthma or who develop asthma. We therefore inoculated 6-day-old mice with sham, RV-A1B, or RV-C15. Inflammasome priming and activation were assessed, and selected mice treated with recombinant IL-1&#x3b2;. Compared to RV-A1B infection, RV-C15 infection induced an exaggerated asthma phenotype, with increased mRNA expression of Il5, Il13, Il25, Il33, Muc5ac, Muc5b, and Clca1; increased lung lineage-negative CD25+CD127+ST2+ ILC2s; increased mucous metaplasia; and increased airway responsiveness. Lung vRNA, induction of pro-inflammatory type 1 cytokines, and inflammasome priming (pro-IL-1&#x3b2; and NLRP3) were not different between the two viruses. However, inflammasome activation (mature IL-1&#x3b2; and caspase-1 p12) was reduced in RV-C15-infected mice compared to RV-A1B-infected mice. A similar deficiency was found in cultured macrophages. Finally, IL-1&#x3b2; treatment decreased RV-C-induced type 2 cytokine and mucus-related gene expression, ILC2s, mucous metaplasia, and airway responsiveness but not lung vRNA level. We conclude that RV-C induces an enhanced asthma phenotype in immature mice. Compared to RV-A, RV-C-induced macrophage inflammasome activation and IL-1&#x3b2; are deficient, permitting exaggerated type 2 inflammation and mucous metaplasia.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s), under exclusive licence to Society for Mucosal Immunology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Mingyuan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University of Michigan Medical School, Ann Arbor, MI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ishikawa</LastName><ForeName>Tomoko</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University of Michigan Medical School, Ann Arbor, MI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stroupe</LastName><ForeName>Claudia C</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University of Michigan Medical School, Ann Arbor, MI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Breckenridge</LastName><ForeName>Haley A</ForeName><Initials>HA</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University of Michigan Medical School, Ann Arbor, MI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bentley</LastName><ForeName>J Kelley</ForeName><Initials>JK</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University of Michigan Medical School, Ann Arbor, MI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hershenson</LastName><ForeName>Marc B</ForeName><Initials>MB</Initials><Identifier Source="ORCID">0000-0001-9436-5593</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics, University of Michigan Medical School, Ann Arbor, MI, USA. mhershen@umich.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular and Integrative Physiology, University of Michigan Medical School, Ann Arbor, MI, USA. mhershen@umich.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AI120526</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI155444</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL134369</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>08</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Mucosal Immunol</MedlineTA><NlmUniqueID>101299742</NlmUniqueID><ISSNLinking>1933-0219</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D058847">Inflammasomes</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Organism" UI="C000623728">Rhinovirus C</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001249" MajorTopicYN="N">Asthma</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003384" MajorTopicYN="N">Coxsackievirus Infections</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004198" MajorTopicYN="N">Disease Susceptibility</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="Y">Enterovirus</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007113" MajorTopicYN="N">Immunity, Innate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016130" MajorTopicYN="N">Immunophenotyping</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058847" MajorTopicYN="N">Inflammasomes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008213" MajorTopicYN="N">Lymphocyte Activation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016131" MajorTopicYN="N">Lymphocyte Subsets</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008264" MajorTopicYN="N">Macrophages</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="Y">Phenotype</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflict of Interest Statement</b>: No conflict</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>3</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>7</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>7</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>8</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>8</Month><Day>6</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>2</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34354243</ArticleId><ArticleId IdType="mid">NIHMS1726828</ArticleId><ArticleId IdType="pmc">PMC8542611</ArticleId><ArticleId IdType="doi">10.1038/s41385-021-00436-0</ArticleId><ArticleId IdType="pii">S1933-0219(22)00230-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lau SKP, Yip CCY, Tsoi H-w, Lee RA, So L-y, Lau Y-l et al. Clinical features and complete genome characterization of a distinct human rhinovirus (HRV) genetic cluster, probably representing a previously undetected HRV Species, HRV-C, associated with acute respiratory illness in children. J Clin Microbiol 2007; 45(11): 3655&#x2013;3664.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2168475</ArticleId><ArticleId IdType="pubmed">17804649</ArticleId></ArticleIdList></Reference><Reference><Citation>Dominguez SR, Briese T, Palacios G, Hui J, Villari J, Kapoor V et al. Multiplex MassTag-PCR for respiratory pathogens in pediatric nasopharyngeal washes negative by conventional diagnostic testing shows a high prevalence of viruses belonging to a newly recognized rhinovirus clade. J Clin Virol 2008; 43(2): 219&#x2013;222.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2603178</ArticleId><ArticleId IdType="pubmed">18674964</ArticleId></ArticleIdList></Reference><Reference><Citation>Simmonds P, McIntyre C, Savolainen-Kopra C, Tapparel C, Mackay IM, Hovi T. Proposals for the classification of human rhinovirus species C into genotypically assigned types. J Gen Virol 2010; 91(10): 2409&#x2013;2419.</Citation><ArticleIdList><ArticleId IdType="pubmed">20610666</ArticleId></ArticleIdList></Reference><Reference><Citation>McIntyre CL, Knowles NJ, Simmonds P. Proposals for the classification of human rhinovirus species A, B and C into genotypically assigned types. J Gen Virol 2013; 94(8): 1791&#x2013;1806.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3749525</ArticleId><ArticleId IdType="pubmed">23677786</ArticleId></ArticleIdList></Reference><Reference><Citation>Bella J, Kolatkar PR, Marlor CW, Greve JM, Rossmann MG. The structure of the two amino-terminal domains of human ICAM-1 suggests how it functions as a rhinovirus receptor and as an LFA-1 integrin ligand. Proc Natl Acad Sci USA 1998; 95(8): 4140&#x2013;4145.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC22455</ArticleId><ArticleId IdType="pubmed">9539703</ArticleId></ArticleIdList></Reference><Reference><Citation>Vlasak M, Roivainen M, Reithmayer M, Goesler I, Laine P, Snyers L et al. The minor receptor group of human rhinovirus (HRV) includes HRV23 and HRV25, but the presence of a lysine in the VP1 HI loop is not sufficient for receptor binding. J Virol 2005; 79(12): 7389&#x2013;7395.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1143622</ArticleId><ArticleId IdType="pubmed">15919894</ArticleId></ArticleIdList></Reference><Reference><Citation>Gern JE, Galagan DM, Jarjour NN, Dick EC, Busse WW. Detection of rhinovirus RNA in lower airway cells during experimentally induced infection. Am J Respir Crit Care Med 1997; 155(3): 1159&#x2013;1161.</Citation><ArticleIdList><ArticleId IdType="pubmed">9117003</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnston SL, Papi A, Bates PJ, Mastronarde JG, Monick MM, Hunninghake GW. Low grade rhinovirus infection induces a prolonged release of IL-8 in pulmonary epithelium. J Immunol 1998; 160(12): 6172&#x2013;6181.</Citation><ArticleIdList><ArticleId IdType="pubmed">9637536</ArticleId></ArticleIdList></Reference><Reference><Citation>Gern JE, Galagan DM, Dick EC. Rhinovirus enters but does not replicate inside airway macrophages. J Allergy Clin Immunol 1994; 93(1): 203&#x2013;203.</Citation></Reference><Reference><Citation>Laza-Stanca V, Stanciu LA, Message SD, Edwards MR, Gern JE, Johnston SL. Rhinovirus replication in human macrophages induces NF-kappaB-dependent tumor necrosis factor alpha production. J Virol 2006; 80(16): 8248&#x2013;8258.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1563804</ArticleId><ArticleId IdType="pubmed">16873280</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosoda M, Yamaya M, Suzuki T, Yamada N, Kamanaka M, Sekizawa K et al. Effects of rhinovirus infection on histamine and cytokine production by cell lines from human mast cells and basophils. J Immunol 2002; 169(3): 1482&#x2013;1491.</Citation><ArticleIdList><ArticleId IdType="pubmed">12133975</ArticleId></ArticleIdList></Reference><Reference><Citation>Akoto C, Davies DE, Swindle EJ. Mast cells are permissive for rhinovirus replication: potential implications for asthma exacerbations. Clin Exp Allergy 2017; 47(3): 351&#x2013;360.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5396281</ArticleId><ArticleId IdType="pubmed">28008678</ArticleId></ArticleIdList></Reference><Reference><Citation>Griggs TF, Bochkov YA, Basnet S, Pasic TR, Brockman-Schneider RA, Palmenberg AC et al. Rhinovirus C targets ciliated airway epithelial cells. Respir Res 2017; 18(1): 84.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5418766</ArticleId><ArticleId IdType="pubmed">28472984</ArticleId></ArticleIdList></Reference><Reference><Citation>Bochkov YA, Watters K, Ashraf S, Griggs TF, Devries MK, Jackson DJ et al. Cadherin-related family member 3, a childhood asthma susceptibility gene product, mediates rhinovirus C binding and replication. Proc Natl Acad Sci USA 2015; 112(17): 5485&#x2013;5490.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4418890</ArticleId><ArticleId IdType="pubmed">25848009</ArticleId></ArticleIdList></Reference><Reference><Citation>Everman JL, Sajuthi S, Saef B, Rios C, Stoner AM, Numata M et al. Functional genomics of CDHR3 confirms its role in HRV-C infection and childhood asthma exacerbations. J Allergy Clin Immunol 2019. 144(4):962&#x2013;971.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6766426</ArticleId><ArticleId IdType="pubmed">30930175</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller EK, Edwards KM, Weinberg GA, Iwane MK, Griffin MR, Hall CB et al. A novel group of rhinoviruses is associated with asthma hospitalizations. J Allergy Clin Immunol 2009; 123(1): 98&#x2013;104.e101.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7112283</ArticleId><ArticleId IdType="pubmed">19027147</ArticleId></ArticleIdList></Reference><Reference><Citation>Bizzintino J, Lee W-M, Laing IA, Vang F, Pappas T, Zhang G et al. Association between human rhinovirus C and severity of acute asthma in children. Eur Respir J 2011; 37(5): 1037&#x2013;1042.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3024467</ArticleId><ArticleId IdType="pubmed">20693244</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox DW, Bizzintino J, Ferrari G, Khoo SK, Zhang G, Whelan S et al. Human rhinovirus species C infection in young children with acute wheeze is associated with increased acute respiratory hospital admissions. Am J Respir Crit Care Medicine 2013; 188(11): 1358&#x2013;1364.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5447292</ArticleId><ArticleId IdType="pubmed">23992536</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-Valencia Y, Hernandez-Hernandez VA, Romero-Espinoza JAI, Coronel-Tellez RH, Castillejos-Lopez M, Hernandez A et al. Detection and characterization of respiratory viruses causing acute respiratory illness and asthma exacerbation in children during three different seasons (2011&#x2013;2014) in Mexico City. Influenza Other RespirViruses 2015; 9(6): 287&#x2013;292.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4605408</ArticleId><ArticleId IdType="pubmed">26289993</ArticleId></ArticleIdList></Reference><Reference><Citation>Fawkner-Corbett DW, Khoo SK, Duarte CM, Bezerra PGM, Bochkov YA, Gern JE et al. Rhinovirus-C detection in children presenting with acute respiratory infection to hospital in Brazil. J Med Virol 2016; 88(1): 58&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4682890</ArticleId><ArticleId IdType="pubmed">26100591</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox DW, Khoo S-K, Zhang G, Lindsay K, Keil AD, Knight G et al. Rhinovirus is the most common virus and rhinovirus-C is the most common species in paediatric intensive care respiratory admissions. Eur Respir J 2018; 52(2).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6295450</ArticleId><ArticleId IdType="pubmed">29976655</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasegawa K, Mansbach JM, Bochkov YA, Gern JE, Piedra PA, Bauer CS et al. Association of rhinovirus C bronchiolitis and immunoglobulin E sensitization during infancy with development of recurrent wheeze. JAMA Pediatrics 2019; 173(6): 544&#x2013;552.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6547078</ArticleId><ArticleId IdType="pubmed">30933255</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasegawa K, Hoptay CE, Harmon B, Celed&#xf3;n JC, Mansbach JM, Piedra PA et al. Association of type 2 cytokines in severe rhinovirus bronchiolitis during infancy with risk of developing asthma: A multicenter prospective study. Allergy; 2019;74:1374&#x2013;1377.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6640081</ArticleId><ArticleId IdType="pubmed">30656708</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubner FJ, Jackson DJ, Evans MD, Gangnon RE, Tisler CJ, Pappas TE et al. Early life rhinovirus wheezing, allergic sensitization, and asthma risk at adolescence. J Allergy Clin Immunol 2017; 139(2): 501&#x2013;507.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5104680</ArticleId><ArticleId IdType="pubmed">27312820</ArticleId></ArticleIdList></Reference><Reference><Citation>van Meel ER, den Dekker HT, Elbert NJ, Jansen PW, Moll HA, Reiss IK et al. A population-based prospective cohort study examining the influence of early-life respiratory tract infections on school-age lung function and asthma. Thorax 2018; 73(2): 167&#x2013;173.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6485606</ArticleId><ArticleId IdType="pubmed">29101282</ArticleId></ArticleIdList></Reference><Reference><Citation>Moraes TJ, Sears MR. Lower respiratory infections in early life are linked to later asthma. Thorax 2018; 73(2): 105&#x2013;106.</Citation><ArticleIdList><ArticleId IdType="pubmed">29170249</ArticleId></ArticleIdList></Reference><Reference><Citation>Martorano LM, Grayson MH. Respiratory viral infections and atopic development: From possible mechanisms to advances in treatment. Eur J Immunol 2018; 48(3): 407&#x2013;414.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5844827</ArticleId><ArticleId IdType="pubmed">29244204</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong JY, Bentley JK, Chung Y, Lei J, Steenrod JM, Chen Q et al. Neonatal rhinovirus induces mucous metaplasia and airways hyperresponsiveness through IL-25 and type 2 innate lymphoid cells. J Allergy Clin Immunol 2014; 134(2): 429&#x2013;439.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4119851</ArticleId><ArticleId IdType="pubmed">24910174</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajput C, Cui T, Han M, Lei J, Hinde JL, Wu Q et al. ROR&#x3b1;-dependent type 2 innate lymphoid cells are required and sufficient for mucous metaplasia in immature mice. Am J Physiol: Lung Cell Mol Physiol 2017; 312(6): L983&#x2013;L993.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5495952</ArticleId><ArticleId IdType="pubmed">28360114</ArticleId></ArticleIdList></Reference><Reference><Citation>Han M, Rajput C, Hong JY, Lei J, Hinde JL, Wu Q et al. The innate cytokines IL-25, IL-33, and TSLP cooperate in the induction of type 2 innate lymphoid cell expansion and mucous metaplasia in rhinovirus-infected immature mice. J Immunol 2017; 199(4): 1308&#x2013;1318.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5548608</ArticleId><ArticleId IdType="pubmed">28701507</ArticleId></ArticleIdList></Reference><Reference><Citation>Han M, Ishikawa T, Bermick JR, Rajput C, Lei J, Goldsmith AM et al. IL-1&#x3b2; prevents ILC2 expansion, type 2 cytokine secretion, and mucus metaplasia in response to early-life rhinovirus infection in mice. Allergy 2020; 2020;75:2005&#x2013;2019</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8066359</ArticleId><ArticleId IdType="pubmed">32086822</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider D, Hong JY, Popova AP, Bowman ER, Linn MJ, McLean AM et al. Neonatal rhinovirus infection induces persistent mucous metaplasia and airways hyperresponsiveness J Immunol 2012; 188: 2894&#x2013;2904.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3294163</ArticleId><ArticleId IdType="pubmed">22331068</ArticleId></ArticleIdList></Reference><Reference><Citation>Han M, Bentley JK, Rajput C, Lei J, Ishikawa T, Jarman CR et al. Inflammasome activation is required for human rhinovirus-induced airway inflammation in na&#xef;ve and allergen-sensitized mice. Mucosal Immunol 2019. 12 (4), 958&#x2013;968</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6668626</ArticleId><ArticleId IdType="pubmed">31089187</ArticleId></ArticleIdList></Reference><Reference><Citation>Saba TG, Chung Y, Hong JY, Sajjan US, Bentley JK, Hershenson MB. Rhinovirus-induced macrophage cytokine expression does not require endocytosis or replication. Am J Respir Cell Mol Biol 2014; 50(5): 974&#x2013;984.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4068949</ArticleId><ArticleId IdType="pubmed">24783958</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashraf S, Brockman-Schneider R, Gern JE. Propagation of rhinovirus-C strains in human airway epithelial cells differentiated at air-liquid interface. In: Jans DA, Ghildyal R (eds). Rhinoviruses: Methods and Protocols. Springer New York: New York, NY, 2015, pp 63&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4441517</ArticleId><ArticleId IdType="pubmed">25261307</ArticleId></ArticleIdList></Reference><Reference><Citation>Bochkov YA, Watters K, Basnet S, Sijapati S, Hill M, Palmenberg AC et al. Mutations in VP1 and 3A proteins improve binding and replication of rhinovirus C15 in HeLa-E8 cells. Virology 2016; 499: 350&#x2013;360.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5110265</ArticleId><ArticleId IdType="pubmed">27743961</ArticleId></ArticleIdList></Reference><Reference><Citation>Franchi L, Eigenbrod T, N&#xfa;&#xf1;ez G. Cutting Edge: TNF-&#x3b1; Mediates Sensitization to ATP and Silica via the NLRP3 Inflammasome in the Absence of Microbial Stimulation. J Immunol 2009; 183(2): 792&#x2013;796.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2754237</ArticleId><ArticleId IdType="pubmed">19542372</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauernfeind FG, Horvath G, Stutz A, Alnemri ES, MacDonald K, Speert D et al. Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J Immunol 2009; 183(2): 787&#x2013;791.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2824855</ArticleId><ArticleId IdType="pubmed">19570822</ArticleId></ArticleIdList></Reference><Reference><Citation>He Y, Hara H, Nunez G. Mechanism and regulation of NLRP3 inflammasome activation. Trends Biochem Sci 2016; 41(12): 1012&#x2013;1021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5123939</ArticleId><ArticleId IdType="pubmed">27669650</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajan JV, Warren SE, Miao EA, Aderem A. Activation of the NLRP3 inflammasome by intracellular poly I:C. 2010; 584(22): 4627&#x2013;4632.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3005299</ArticleId><ArticleId IdType="pubmed">20971108</ArticleId></ArticleIdList></Reference><Reference><Citation>Franchi L, Eigenbrod T, Mu&#xf1;oz-Planillo R, Ozkurede U, Kim Y-G, Chakrabarti A et al. Cytosolic double-stranded RNA activates the NLRP3 inflammasome via MAVS-induced membrane permeabilization and K+ efflux. J Immunol 2014; 193(8): 4214&#x2013;4222.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4185247</ArticleId><ArticleId IdType="pubmed">25225670</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Hu L, Liu Y, Huang L, Mu Y, Cai X et al. DDX19A senses viral RNA and mediates NLRP3-dependent inflammasome activation. J Immunol 2015; 195(12): 5732&#x2013;5749.</Citation><ArticleIdList><ArticleId IdType="pubmed">26538395</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Hill MG, Klose T, Chen Z, Watters K, Bochkov YA et al. Atomic structure of a rhinovirus C, a virus species linked to severe childhood asthma. Proc Natl Acad Sci USA 2016; 113(32): 8997&#x2013;9002.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4987780</ArticleId><ArticleId IdType="pubmed">27511920</ArticleId></ArticleIdList></Reference><Reference><Citation>Mercer J, Greber UF. Virus interactions with endocytic pathways in macrophages and dendritic cells. Trends Microbiol 2013; 21(8): 380&#x2013;388.</Citation><ArticleIdList><ArticleId IdType="pubmed">23830563</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikitina E, Larionova I, Choinzonov E, Kzhyshkowska J. Monocytes and macrophages as viral targets and reservoirs. Int J Mol Sci; 19(9).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6163364</ArticleId><ArticleId IdType="pubmed">30231586</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuler BA, Schreiber MT, Li L, Mokry M, Kingdon ML, Raugi DN et al. Major and minor group rhinoviruses elicit differential signaling and cytokine responses as a function of receptor-mediated signal transduction. PLoS One 2014; 9:e93897.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3988043</ArticleId><ArticleId IdType="pubmed">24736642</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajput C, Han M, J.K. B, Lei J, Ishikawa T, Wu Q et al. Enterovirus D68 infection induces IL-17-dependent neutrophilic airway inflammation and hyperresponsiveness. JCI Insight 2018.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6141171</ArticleId><ArticleId IdType="pubmed">30135310</ArticleId></ArticleIdList></Reference><Reference><Citation>Contoli M, Message SD, Laza-Stanca V, Edwards MR, Wark PA, Bartlett NW et al. Role of deficient type III interferon-lambda production in asthma exacerbations. Nat Med 2006; 12: 1023&#x2013;1026.</Citation><ArticleIdList><ArticleId IdType="pubmed">16906156</ArticleId></ArticleIdList></Reference><Reference><Citation>Han M, Chung Y, Hong JY, Rajput C, Lei J, Hinde JL et al. Toll-like receptor 2-expressing macrophages are required and sufficient for rhinovirus-induced airway inflammation. J Allergy Clin Immunol 2016; 138(6): 1619&#x2013;1630.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5061583</ArticleId><ArticleId IdType="pubmed">27084403</ArticleId></ArticleIdList></Reference><Reference><Citation>Park EK, Jung HS, Yang HI, Yoo MC, Kim C, Kim KS. Optimized THP-1 differentiation is required for the detection of responses to weak stimuli. Inflammation Res 2007; 56(1): 45&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">17334670</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>